Logo
x

Search

Subscribe Now

Chronic obstructive pulmonary disease

PharmaShots Interview: Kaia Health's Jonas Duss Shares Insights on COPD Pulmonary Rehabilitation App

PharmaShots Interview: Kaia Health's Jonas Duss Shares Insights on COPD Pulmonary Rehabilitation App

  • January 19, 2021
AstraZeneca's Trixeo Aerosphere Receives EU's Approval for the Maintenance Treatment of COPD

AstraZeneca's Trixeo Aerosphere Receives EU's Approval for the Maintenance Treatment of COPD

  • December 14, 2020
AstraZeneca to Present Results of Breztri Aerosphere in P-III ETHOS Study at ERS International Congress 2020

AstraZeneca to Present Results of Breztri Aerosphere in P-III ETHOS Study at ERS International Congress 2020

  • September 7, 2020
AstraZeneca Reports Results of Breztri Aerosphere in P-III ETHOS Study for Chronic Obstructive Pulmonary Disease

AstraZeneca Reports Results of Breztri Aerosphere in P-III ETHOS Study for Chronic Obstructive Pulmonary Disease

  • August 28, 2019
GSK's Trelegy Ellipta (Fluticasone Furoate/Umeclidinium/Vilanterol ‘FF/UMEC/VI') Receives Expanded Level Approval from EU for COPD

GSK's Trelegy Ellipta (Fluticasone Furoate/Umeclidinium/Vilanterol ‘FF/UMEC/VI') Receives Expanded Level Approval from EU for COPD

  • November 13, 2018
AstraZeneca announces Results of AERISTO P-IIIb trial for Bevespi Aerosphere in COPD patients

AstraZeneca announces Results of AERISTO P-IIIb trial for Bevespi Aerosphere in COPD patients

  • August 24, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.